Earnings ·
Kestra Medical Technologies reported first-quarter fiscal 2027 results ending July 31, 2026
KMTSKestra Medical Technologies, Ltd.
Kestra Medical Technologies reported first-quarter fiscal 2027 results ending July 31, 2026. Revenue increased 60% to $31.0 million, while gross margin expanded to 56.5%. The company raised its full-year FY27 revenue guidance to $141 million from the previous estimate of $137 million. GAAP net loss widened to $44.1 million compared to $25.8 million in the prior year period, driven by increased operating expenses and a $6.3 million loss on debt extinguishment. Cash and investments totaled $244.7 million as of July 31, 2026. Kestra Medical Technologies operates in the wearable medical device and digital healthcare industry.